Abstract
The impact of replacing the National Cholesterol Education Program (NCEP)/Adult Treatment Program (ATP) III cholesterol guidelines with the new 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for primary prevention of cardiovascular disease is unclear. We used risk factor and 10-year clinical event rate data from MESA, combined with estimates of efficacy of moderate and high-intensity statin therapy from meta-analyses of statin primary prevention trials to estimate (a) the change in number of subjects eligible for drug therapy and (2) the anticipated reduction in atherosclerotic cardiovascular disease (ASCVD) events and increment in type 2 diabetes mellitus (T2DM) associated with the change in cholesterol guidelines. Of the 6,814 MESA participants, 5,437 were not on statins at baseline and had complete data for analysis (mean age 61.4±10.3). Using the NCEP/ATP III guidelines, 1,334 (24.5%) would have been eligible for statin therapy compared with 3,015 (55.5%) under the new ACC/AHA guidelines. Among the subset of newly eligible, 127/1,742 (7.3%) had an ASCVD event during 10years of follow-up. Assuming 10years of moderate-intensity statin therapy, the estimated absolute reduction in ASCVD ev...Continue Reading
References
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 13, 2001·JAMA : the Journal of the American Medical Association·R B D'AgostinoUNKNOWN CHD Risk Prediction Group
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu
Oct 25, 2002·American Journal of Epidemiology·Diane E BildRussell P Tracy
Apr 11, 2003·Lancet·Peter S SeverUNKNOWN ASCOT investigators
Jun 24, 2004·Journal of General Internal Medicine·Jeffrey J EllisA Mark Fendrick
Jul 14, 2004·Circulation·Scott M GrundyUNKNOWN American Heart Association
Sep 11, 2004·Journal of the American College of Cardiology·Scott M GrundyUNKNOWN Coordinating Committee of the National Cholesterol Education Program
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Nov 22, 2008·Journal of the American College of Cardiology·Edward J MillsDan Perri
Jul 29, 2009·Circulation·Joseph YeboahDavid M Herrington
Oct 2, 2009·Diabetes Care·Swapnil N RajpathakPaul M Ridker
Feb 20, 2010·Lancet·Naveed SattarIan Ford
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
Apr 19, 2012·JAMA : the Journal of the American Medical Association·James S FloydBruce M Psaty
Oct 2, 2013·Journal of Clinical Lipidology·Melissa Y WeiTerry A Jacobson
Nov 23, 2013·BMJ : British Medical Journal·Jeanne Lenzer
Nov 26, 2013·Lancet·Paul M Ridker, Nancy R Cook
Nov 28, 2013·JAMA : the Journal of the American Medical Association·Fiona C TaylorShah Ebrahim
Dec 4, 2013·JAMA : the Journal of the American Medical Association·John P A Ioannidis
Dec 18, 2013·Circulation·Paul MuntnerGeorge Howard
Jan 28, 2014·Current Cardiology Reports·Casper N Bang, Peter M Okin
Mar 22, 2014·The New England Journal of Medicine·Michael J PencinaEric D Peterson
Apr 1, 2014·JAMA : the Journal of the American Medical Association·Paul MuntnerMonika M Safford
Citations
Feb 20, 2016·Journal of Clinical Lipidology·Guadalupe EcheverríaAttilio Rigotti
Jan 17, 2016·Atherosclerosis·Yashashwi PokharelSalim S Virani
Oct 23, 2015·Clinical Pharmacology and Therapeutics·G P S Shantha, J G Robinson
May 22, 2016·Journal of Clinical Lipidology·Salim S ViraniChristie M Ballantyne
Sep 8, 2015·Journal of Clinical Lipidology·Peter F Belamarich
Aug 16, 2016·International Journal of Environmental Research and Public Health·Nonanzit Pérez-HernándezJosé Manuel Rodríguez-Pérez
Oct 21, 2016·Expert Opinion on Therapeutic Patents·Eduardo Filipe OliveiraPedro Alexandrino Fernandes
Sep 26, 2016·JACC. Cardiovascular Imaging·Amir A MahabadiUNKNOWN Heinz Nixdorf Recall Study Investigators
Oct 16, 2016·Global Heart·Michael J BlahaPhilip Greenland
Feb 6, 2016·Clinical Cardiology·Marcio Sommer BittencourtPaulo A Lotufo
May 13, 2017·Journal of the American Heart Association·Waqas T QureshiCarlos J Rodriguez
Feb 13, 2016·Circulation·Ian FordChris J Packard
Nov 9, 2018·Journal of Computer Assisted Tomography·Ying LiJason Hom
Nov 20, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Christina NgAngela Cheng-Lai
Oct 26, 2018·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Ying LiMax Wintermark
Dec 15, 2018·Muscle & Nerve·Heather M Ochs-BalcomGeorgirene D Vladutiu
Oct 27, 2018·Journal of Managed Care & Specialty Pharmacy·Xue HanJeffrey McCombs
Jul 28, 2020·Radiology. Cardiothoracic Imaging·Ashley ChorathVeit Sandfort
Feb 6, 2017·Current Cardiovascular Risk Reports·Rebeccah A McKibbenErin D Michos
Apr 10, 2019·Journal of Clinical Pharmacy and Therapeutics·Nancy Borja-HartIrma B Ancheta
Feb 10, 2021·BMC Cardiovascular Disorders·Fang AnJihong Zhao